Pathogenicity of anti-U1RNP antibodies in neuropsychiatric systemic lupus erythematous
Project/Area Number |
25461472
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Collagenous pathology/Allergology
|
Research Institution | Wakayama Medical University (2015) Kyoto University (2013-2014) |
Principal Investigator |
FUJII Takao 和歌山県立医科大学, 医学部, 教授 (70255462)
|
Co-Investigator(Kenkyū-buntansha) |
HASHIMOTO Motomu 京都大学, 大学院医学研究科, 助教 (60512845)
|
Research Collaborator |
KONDO Seiko
ISHIGOOKA Nozomi
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 全身性エリテマトーデス / 中枢神経障害 / 自己抗体 / サイトカイン / 抗核抗体 / 脳脊髄液 / ケモカイン / 中枢神経症状 |
Outline of Final Research Achievements |
In patients with systemic lupus erythematosus (SLE), neuropsychiatric manifestations (NPSLE) is a refractory disorder, because their disease-specific markers and treatment strategy are not well determined. The present study shows a certain subset of NPSLE, which has a link of cerebrospinal fluid (CSF)-autoantibodies, CSF-inflammatory mediators, and blood brain barrier (BBB) permeabilities. Especially, CSF-IL-6 concentration was elevated in association with anti-NR2 antibodies by BBB injury. Also, anti-U1RNP antibodies may activate IFN-α production intrathecally and up-regulate CSF-IL-6 in the presence of CSF-anti-NR2 antibodies. We can conclude that both anti-NR2 and U1RNP antibody detections in NPSLE may be useful not only for diagnosis, but also treatment decision in primary NPSLE patients.
|
Report
(4 results)
Research Products
(20 results)
-
-
[Journal Article] Periodontitis and Porphyromonas gingivalis in Preclinical Stage of Arthritis Patients.2015
Author(s)
Hashimoto M, Yamazaki T, Hamaguchi M, Morimoto T, Yamori M, Asai K, Isobe Y, Furu M, Ito H, Fujii T, et al.
-
Journal Title
NAID
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice2014
Author(s)
Fujita Y, Fujii T, Mimori T, Sato T, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Kawanami T, Tanaka M, Masaki Y, Fukushima T, Okazaki T and Umehara H
-
Journal Title
Journal of immunology
Volume: 192
Issue: 3
Pages: 979-984
DOI
Related Report
Peer Reviewed
-
[Journal Article] Serum milk fat globule epidermal growth factor 8 elevation may subdivide systemic lupus erythematosus into two pathophysiologically distinct subsets2014
Author(s)
Yamamoto, N., Yamaguchi, H., Ohmura, K., Yokoyama, T., Yoshifuji, H., Yukawa, N., Kawabata, D., Fujii, T., Morita, S., Nagata, S. and Mimori, T.
-
Journal Title
Lupus
Volume: 23
Issue: 4
Pages: 386-394
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Presentation] Neuropsychiatric SLEにおける血液脳関門の透過性と脳脊髄液中の炎症性メディエーターとの関係2016
Author(s)
石郷岡 望, 藤井 隆夫, 近藤 聖子, 村上 孝作, 笹井 蘭, 橋本 求, 井村 嘉孝, 湯川 尚一郎, 吉藤 元, 田中 真生, 大村 浩一郎, 三森 経世
Organizer
第60回日本リウマチ学会総会
Place of Presentation
横浜
Year and Date
2016-04-21
Related Report
-
-
-
-
-
-
-
-
-
-
-
-